| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014721773 |
| P356 | DOI | 10.1038/362350A0 |
| P698 | PubMed publication ID | 8384323 |
| P2093 | author name string | H Yu | |
| C D Strader | |||
| M A Cascieri | |||
| T M Fong | |||
| A Bansal | |||
| C Swain | |||
| P2860 | cites work | Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides | Q27642117 |
| Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms | Q28255703 | ||
| Acetylcholine binding by a synthetic receptor: implications for biological recognition | Q28269893 | ||
| Aromatic-aromatic interaction: a mechanism of protein structure stabilization | Q29620587 | ||
| Molecular characterization of a functional cDNA encoding the rat substance P receptor | Q33891305 | ||
| Receptors for substance P and related neurokinins | Q35455042 | ||
| Mammalian Tachykinin Receptors | Q37178892 | ||
| Pharmacological properties of a potent and selective nonpeptide substance P antagonist | Q37621800 | ||
| Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation | Q37646935 | ||
| Protein engineering and the study of structure--function relationships in receptors | Q37948723 | ||
| Structural basis of beta-adrenergic receptor function. | Q41235089 | ||
| The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst | Q44393136 | ||
| Hydrophobic organization of membrane proteins | Q46531578 | ||
| SIRIUS. An automated method for the analysis of the preferred packing arrangements between protein groups | Q47640975 | ||
| A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor | Q67679280 | ||
| Aromatic rings act as hydrogen bond acceptors | Q67936192 | ||
| P433 | issue | 6418 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 350-3 | |
| P577 | publication date | 1993-03-25 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345 | |
| P478 | volume | 362 |
| Q58853853 | A Locus of the Gonadotropin-releasing Hormone Receptor That Differentiates Agonist and Antagonist Binding Sites |
| Q33912621 | A single amino acid of the human and rat neurotensin receptors (subtype 1) determining the pharmacological profile of a species-selective neurotensin agonist |
| Q57944129 | A theoretical investigation of the nature of the π-H interaction in ethene–H2O, benzene–H2O, and benzene–(H2O)2 |
| Q39030338 | Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. |
| Q35679031 | Agonists and antagonists bind to different domains of the cloned kappa opioid receptor |
| Q44989009 | An ab initio theoretical prediction: an antiaromatic ring pi-dihydrogen bond accompanied by two secondary interactions in a "wheel with a pair of pedals" shaped complex FH . . . C4H4 . . . HF. |
| Q73604181 | An automated method for predicting the positions of hydrogen-bonding atoms in binding sites |
| Q41358948 | Aspartate mutation distinguishes ETA but not ETB receptor subtype‐selective ligand binding while abolishing phospholipase C activation in both receptors |
| Q28220437 | Biophysical methods to study ligand-receptor interactions of neuropeptide Y |
| Q58234708 | Building a model of interaction at the NK-2 receptors: Polycondensed heterocycles containing the pyrimidoindole skeleton |
| Q28137628 | CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology |
| Q48245176 | Cation-π interactions in CREBBP bromodomain inhibition: an electrostatic model for small-molecule binding affinity and selectivity |
| Q41113324 | Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist |
| Q41078553 | Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering |
| Q41508037 | Conserved HisVI-17 of the NK-1 receptor is involved in binding of non-peptide antagonists but not substance P. |
| Q44341635 | Construction of a high affinity zinc switch in the kappa-opioid receptor. |
| Q41361735 | Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor. |
| Q90411741 | Crystal structure of the human NK1 tachykinin receptor |
| Q35232919 | Delineation of a region in the B2 bradykinin receptor that is essential for high-affinity agonist binding |
| Q24563290 | Delineation of the peptide binding site of the human galanin receptor |
| Q35611810 | Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors |
| Q73922916 | Effect of single point mutations of the human tachykinin NK1 receptor on antagonist affinity |
| Q42370128 | Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B. |
| Q51518968 | Empirical formulation and parameterization of cation-π interactions for protein modeling. |
| Q41575902 | Engineering of metal-ion sites as distance constraints in structural and functional analysis of 7TM receptors |
| Q28141454 | Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor |
| Q33263397 | Fluorescence spectroscopy of jet-cooled chiral (+/-)-indan-1-ol and its cluster with (+/-)-methyl- and ethyl-lactate |
| Q40954597 | G-protein-coupled receptors in insect cells. |
| Q36686447 | Heterogeneity of the Calcitonin Receptor: Functional Aspects in Osteoclasts and Other Sites |
| Q41442386 | High‐level Expression of the Human Neurokinin‐1 Receptor in Mammalian Cell Lines using the Semliki Forest Virus Expression System |
| Q41501042 | How receptor mutagenesis may confirm or confuse receptor classification. |
| Q33796897 | Identification of an adenosine receptor domain specifically involved in binding of 5'-substituted adenosine agonists |
| Q38304548 | Identification of an epitope in the substance P receptor important for recognition of the common carboxyl-terminal tachykinin sequence |
| Q46097338 | Identification of potential tyrosine-containing endocytic motifs in the carboxyl-tail and seventh transmembrane domain of the neurokinin 1 receptor |
| Q41379502 | Mapping peptide-binding domains of the substance P (NK-1) receptor from P388D1 cells with photolabile agonists |
| Q34073960 | Mapping substance P binding sites on the neurokinin-1 receptor using genetic incorporation of a photoreactive amino acid |
| Q89937684 | Mas-related G protein coupled receptor-X2: A potential new target for modulating mast cell-mediated allergic and inflammatory diseases |
| Q41478933 | Metal-ion sites as structural and functional probes of helix-helix interactions in 7TM receptors. |
| Q40175249 | Modeling and docking the endothelin G-protein-coupled receptor |
| Q73798615 | Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement |
| Q41547558 | Modes of peptide binding in G protein-coupled receptors |
| Q35210290 | Molecular Architecture of G Protein-Coupled Receptors. |
| Q36994139 | Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor. |
| Q42365925 | Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptor |
| Q40714433 | Molecular characterization of the substance P*neurokinin-1 receptor complex: development of an experimentally based model. |
| Q42158406 | Molecular recognition of peptide and non-peptide ligands by the extracellular domains of neurohypophysial hormone receptors |
| Q42541576 | Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist |
| Q41143400 | Mutational analysis of neurokinin receptor function |
| Q35874315 | Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission |
| Q51659627 | Pharmacological characterisation of neurokinin receptors mediating anion secretion in rat descending colon mucosa. |
| Q73253751 | Possible ligand-receptor interactions for NK1 antagonists as observed in their crystal structures |
| Q44488085 | Probing the binding pocket and endocytosis of a G protein-coupled receptor in live cells reported by a spin-labeled substance P agonist |
| Q36761705 | Probing weakly polar interactions in cytochrome c |
| Q51559839 | Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids. |
| Q44341639 | Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition |
| Q41330111 | Separable Binding Sites for the Natural Agonist Endothelin-1 and the Non-Peptide Antagonist Bosentan on Human Endothelin-A Receptors |
| Q42674144 | Shared determinants of receptor binding for subtype selective, and dual endothelin-angiotensin antagonists on the AT1 angiotensin II receptor |
| Q40524533 | Signal sorting by G-protein-linked receptors. |
| Q41287153 | Small molecule ligands for oxytocin and vasopressin receptors |
| Q52566266 | Structural determinants of neurotransmitter transport using cross-species chimeras: studies on serotonin transporter. |
| Q40465220 | Tachykinin receptors in gastrointestinal motility |
| Q24317745 | The human CD46 molecule is a receptor for measles virus (Edmonston strain) |
| Q64929504 | The neurokinin-1 and neurokinin-2 receptor binding sites of MDL103,392 differ. |
| Q29306227 | The tachykinin NK1 receptor. Part I: Ligands and mechanisms of cellular activation |
| Q38298735 | Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor |
| Q36399333 | Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors. |
| Q74455617 | Two related neurokinin-1 receptor antagonists have overlapping but different binding sites |
| Q35619714 | Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor |
| Q43191221 | UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation |
Search more.